Daratumumab Monotherapy Shows Durable Responses in Relapsed AL Amyloidosis
A single-center retrospective analysis of 40 patients with relapsed AL amyloidosis found that daratumumab monotherapy produced hematologic responses in 72.5 ...
A single-center retrospective analysis of 40 patients with relapsed AL amyloidosis found that daratumumab monotherapy produced hematologic responses in 72.5 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.